- Home
- IOR vs YI Comparison
IOR vs YI Comparison
Compare IOR & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOR
- YI
- Stock Information
- Founded
- IOR 1984
- YI 2010
- Country
- IOR United States
- YI China
- Employees
- IOR N/A
- YI N/A
- Industry
- IOR Real Estate Investment Trusts
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- IOR Real Estate
- YI Consumer Staples
- Exchange
- IOR Nasdaq
- YI Nasdaq
- Market Cap
- IOR 72.8M
- YI 60.7M
- IPO Year
- IOR N/A
- YI N/A
- Fundamental
- Price
- IOR $17.75
- YI $4.88
- Analyst Decision
- IOR
- YI
- Analyst Count
- IOR 0
- YI 0
- Target Price
- IOR N/A
- YI N/A
- AVG Volume (30 Days)
- IOR 126.0
- YI 27.5K
- Earning Date
- IOR 11-06-2025
- YI 11-26-2025
- Dividend Yield
- IOR N/A
- YI N/A
- EPS Growth
- IOR N/A
- YI N/A
- EPS
- IOR 1.06
- YI N/A
- Revenue
- IOR N/A
- YI $1,979,883,442.00
- Revenue This Year
- IOR N/A
- YI N/A
- Revenue Next Year
- IOR N/A
- YI N/A
- P/E Ratio
- IOR $17.04
- YI N/A
- Revenue Growth
- IOR N/A
- YI N/A
- 52 Week Low
- IOR $16.01
- YI $4.15
- 52 Week High
- IOR $19.69
- YI $11.90
- Technical
- Relative Strength Index (RSI)
- IOR 43.18
- YI 37.62
- Support Level
- IOR $17.75
- YI $4.48
- Resistance Level
- IOR $19.00
- YI $4.76
- Average True Range (ATR)
- IOR 0.08
- YI 0.24
- MACD
- IOR -0.04
- YI 0.03
- Stochastic Oscillator
- IOR 0.00
- YI 36.36
About IOR Income Opportunity Realty Investors Inc.
Income Opportunity Realty Investors Inc is a U.S.-based company that is an externally managed company that invests in mortgage notes receivables and real property. The business of the company is managed by Pillar Income Asset Management, Inc. The company's activities include locating, evaluating and recommending investment opportunities. Pillar also arranges its debt and equity financing with unaffiliated independent third party lenders and investors.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.